QY4-17970-44245
3 vaccinations
2 coded responses
23 check-ins
2 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 974 / OR
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 1 — Pfizer-BioNTech
-
2021-01-12
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-14
Survey response — days 1–6 daily, dose 1MedDRA: Dry skin, Skin exfoliation — Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteFree text: Skin dry and peeling on palms - may be unrelatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-15
- 2021-01-16
- 2021-01-17
-
2021-01-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-18
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-19
- 2021-01-26
- 2021-02-02
-
2021-02-05
Dose 2 — Pfizer-BioNTech
- 2021-02-22
- 2021-02-28
- 2021-03-05
- 2021-03-14
- 2021-03-19
- 2021-05-07
- 2021-08-06
-
2021-08-30
Dose 3 — Pfizer-BioNTech
- 2021-10-01
- 2021-10-04
- 2021-10-11
- 2021-11-29
- 2022-02-28
-
2022-08-30
Survey response — 12 months, dose 3MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-08-30
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-08-31
-
2022-09-07
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-02-05 | Pfizer-BioNTech | |
| 3 | 2021-08-30 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-13 | priority 2/3 | |
| 2021-01-18 | priority 2/3 | |
| 2022-08-30 | Successful 2022-09-07 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Skin dry and peeling on palms - may be unrelated
Release 12 — 12 months, dose 3
Symptoms: Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SRO | Dry skin | ✓ | ✓ | ✓ |
| SRO | Skin exfoliation | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release